Latanoprost/Timolol Viatris (Timolol Maleate, Latanoprost)

Latanoprost/Timolol is indicated for conditions affecting intra‑ocular pressure within the glaucoma disease family.

• Open-angle glaucoma: lowers intra‑ocular pressure to prevent optic nerve damage
• Ocular hypertension: reduces elevated eye pressure to lower risk of glaucoma development
• Secondary open-angle glaucoma: helps control pressure when caused by other ocular conditions

• Latanoprost acts as a prostaglandin F2α analog, increasing uveoscleral outflow of aqueous humor, while Timolol maleate non‑selectively blocks beta‑adrenergic receptors in the ciliary body, decreasing aqueous humor production. The combined actions result in a net reduction of intra‑ocular pressure, helping to preserve optic nerve function.

Common Side Effects

• Eye irritation or burning sensation
• Blurred vision shortly after instillation
• Redness of the conjunctiva
• Itching or mild allergic reaction on the eyelid
• Dry eye or foreign‑body sensation
• Increased pigmentation of the iris

Serious or Rare Side Effects

• Severe allergic reaction with swelling of the eyelid or face
• Unexpected rise in intra‑ocular pressure (rebound effect)
• Systemic beta‑blocker effects such as bradycardia, hypotension, or bronchospasm
• Chest pain or signs of heart failure
• Acute angle‑closure glaucoma
• Vision loss

Before initiating therapy, evaluate patient-specific risk factors and monitor for adverse events.

• Assess cardiovascular status: avoid in patients with severe bradycardia, heart block, or decompensated heart failure
• Monitor respiratory function: caution in asthma or chronic obstructive pulmonary disease
• Check for sulfonamide or prostaglandin allergy: discontinue if hypersensitivity occurs
• Avoid abrupt discontinuation: may cause rebound intra‑ocular pressure elevation
• Pregnancy and lactation: use only if potential benefit justifies potential risk to the fetus or infant
• Store at room temperature: keep in original container, protect from light and moisture

Latanoprost/Timolol may interact with other systemic or ocular agents; review concomitant medications.

Major Interactions (Avoid)

• Systemic non‑selective beta‑blockers (e.g., propranolol): additive bradycardia or hypotension
• Other ocular hypotensive agents (e.g., carbonic anhydrase inhibitors): excessive IOP lowering
• Sympathomimetic eye drops (e.g., epinephrine): antagonistic effect reducing efficacy

Moderate Interactions (Monitor Closely):\n- Calcium channel blockers: may influence ocular blood flow and IOP response

• Anticholinergic ophthalmic drops: possible alteration of pupil dynamics
• Systemic antihypertensives: monitor blood pressure for additive lowering